Transplantation of human cord blood-derived endothelial progenitor cells (EPCs) is reported to contribute to neovascularization in various ischemic diseases. However, the possible beneficial role and underlying mechanisms in diabetes-impaired wound healing have been less well characterized. In this study, EPC transplantation stimulated keratinocyte and fibroblast proliferation substantially as early as 3 days after injury, leading to significantly accelerated wound closure in streptozotocin-induced diabetic nude mice, compared to PBS control. RT-PCR analysis showed that EPCs secreted various wound healing-related growth factors. Among them, keratinocyte growth factor and platelet-derived growth factor were highly expressed in the EPCs and were present at substantial levels in the EPC-injected dermal tissue. Using EPC-conditioned medium (CM), we found that paracrine factors from EPCs directly exerted mitogenic and chemotactic effects on keratinocytes and fibroblasts. Moreover, injection of EPC-CM alone into the same diabetic wound mice promoted wound healing and increased neovascularization to a similar extent as achieved with EPC transplantation. These results indicate that the beneficial effect of EPC transplantation on diabetic wounds was mainly achieved by their direct paracrine action on keratinocytes, fibroblasts, and endothelial cells, rather than through their physical engraftment into host tissues (vasculogenesis). In addition, EPC-CM was shown to be therapeutically equivalent to EPCs, at least for the treatment of diabetic dermal wounds, suggesting that conditioned medium may serve as a novel therapeutic option that is free from allograft-associated immune rejection concern.
INTRODUCTION
associated with decreased peripheral blood flow and which remain difficult to heal using current therapeutic approaches. Furthermore, EPCs stimulate endogenous Endothelial progenitor cells (EPCs) are endothelial precursors involved in the revascularization of injured angiogenesis by secreting a variety of angiogenic growth factors, which implies that paracrine factors released tissue and tissue repair (1) . The therapeutic potential of these EPCs has been reported in animal models and in from EPCs could directly stimulate keratinocyte and fibroblast proliferation during the wound healing process humans with ischemic diseases, including myocardial infarction, stroke, and peripheral arterial diseases (6, (7,17) . The wound healing repair process is a well-orches- 16, 18) . We previously demonstrated that the local injection of EPCs into the excisional dermal wounds of nor-trated integration of the multiple biological and molecular events that occur during inflammation, cell migra-mal mice significantly accelerated wound healing and promoted neovascularization of granulation tissues (20) . tion/proliferation, and extracellular matrix deposition (19) . Repair occurs through the coordinated action of Thus, EPC transplantation could be beneficial for the treatment of wounds that resist healing, which are often many growth factors and cytokines and through the in-terplay of different cell types, such as inflammatory (HDF, gifted by Kim DS, Chung-Ang University, Korea) cells were cultured in DMEM (Invitrogen, Carlsbad, cells, fibroblasts, keratinocytes, and endothelial cells (25) . Normal wounds without underlying pathophysio-CA, USA) plus 10% fetal bovine serum. Hek001 (human keratinocyte, gifted by Kim DS, Chung-Ang Uni-logical defects heal readily via the orderly progression of the healing process. In contrast, wounds in patients versity, Korea) cells were cultured in keratinocyte serum-free media (Invitrogen) with 5 ng/ml of human with preexisting pathophysiological abnormalities such as diabetes do not. The wound-healing deficiency of dia-recombinant epidermal growth factor (EGF, Invitrogen) and 2 mM of L-glutamine. betic wounds can be attributed to a number of factors, such as decreased production of growth factors, reduced Diabetic Dermal Wound Animal Model angiogenesis, and impaired migration and proliferation of keratinocytes and fibroblasts. In addition, a recent To induce diabetes in immunodeficient mice, a single high dose of STZ (Sigma, St. Louis, MO, USA; 225 mg/ study in diabetic mice demonstrated that a reduced number of EPCs in the bloodstream and in wound tissues is kg) was intraperitoneally injected into Balb/c nude mice (previously fasted for 16 h, 7-8 weeks old, male, body another crucial cause of impaired diabetic wound healing (5) . Indeed, the peripheral blood of diabetic patients weight 17-23 g, Japan SLC Inc., Shizuoka, Japan) (26) . In this study, a low-dose STZ protocol failed to induce has significantly fewer EPCs than that of normal subjects (4, 11) . Moreover, EPCs from diabetic mice im-hyperglycemia in Balb/c nude mice, as previously reported (15) . Every week after STZ administration, serum paired nevoascularization when injected into an ischemic disease animal model, whereas EPCs from normal glucose levels were measured using an Accu-Check Advantage glucometer (Roche, Indianopolis, IN, USA) un-mice significantly improved blood flow in injured tissues (21) . der the nonfasting status. Mice with a plasma glucose level of >300 mg/dl (in normal Balb/c nude mice, glu-Based on the above data, a sufficient supply of EPCs isolated from a healthy source such as human cord blood cose level was around 100 mg/dl) at 3 weeks after injection were regarded as having STZ-induced diabetes (26) . was hypothesized to restore the impaired wound healing process in diabetic wounds. The present study investi-To investigate the effect of EPCs on diabetic wound healing, STZ-induced diabetic mice were anesthetized gated the wound healing role of human cord bloodderived EPCs in streptozotocin (STZ)-induced diabetic with an intraperitoneal injection of ketamine-xylazine (79.5 mg/kg and 9.1 mg/kg, respectively), after which mice. Furthermore, this study addressed the major mechanism involved in the EPC-mediated wound healing pro-two full-thickness excisional wounds (upper and lower wounds were separated by 2.5 cm) were created on the cess by comparing the EPCs-transplanted and EPC-CMinjected wound. dorso-lateral area using a standard skin biopsy punch (0.5 cm in diameter, Acuderm Inc., Fort Lauderdale, FL, MATERIALS AND METHODS USA). Immediately after surgery, EPCs (1 × 10 6 cells Cell Culture suspended in 60 µl of PBS) and 60 µl of PBS were injected at three different intact dermis sites near the EPCs were isolated as described previously by culturing CD34-positive cells from human umbilical cord upper and lower (or lower and upper wound to rule out the influence of wound location) wounds created on the bloods in the endothelial growth medium (EGM)-2MV Singlequot (Clonetics, Walkersville, MD, USA) for 2-3 same mice to rule out the interanimal variance caused by the differing degrees of hyperglycemia among the weeks (20) . These cells were found to express CD31, KDR, and Tie2, and also to exhibit other properties con-STZ-induced mice. To examine the paracrine effect of EPCs, 100 µl of M199 basal medium or concentrated sistent with the existing definitions of an EPC phenotype, such as uptake of acetylated LDL and tube forma-EPC-CM (collected from 1 × 10 6 EPCs) were injected into wounds with the same experimental method de-tion on Matrigel (9) . The Institutional Review Board at CHA University approved all protocols, and informed scribed above. All procedures were performed with the approval of CHA University Institutional Animal Care consent was obtained from all donors.
For experiments performed with conditioned medium and Use Committee (IACUC). (CM) from EPCs (EPC-CM), the CM was prepared by Wound Analysis culturing EPCs in serum-free M199 media (Clonetics) at 37°C for 24 h and was cleared out and concentrated
The open wound area was measured on days 0, 3, 5, 7, 9, and 12 after treatment using a method described by centrifugation using Microcon (MW cutoff = 10K, Amicon Division, Danvers, MA, USA). Pam212 (mu-previously (20) . Briefly, wounds were documented with a digital camera and their images were analyzed using rine keratinocyte, gift by Kim TY, Catholic University of Korea, Korea), NIH3T3 (murine fibroblast, ATCC, Image-Pro Plus (Media Cybernetics, Inc., Silver Spring, MD, USA) by tracing the wound margin and calculating Manassas, VA, USA), and human dermal fibroblast the pixel area. Pixel counts were then normalized to the 5′-GGGACTATCCACCTGCAAGA-3′ and 5′-CGGAG CTCTGATGTGTTGAA-3′; hTGF-β2, 5′-AAAATAG scale of the metric ruler that was photographed with each wound. Measurement was performed in duplicate, ACATGCCGCCCTT-3′ and 5′-CTTTTGGGTTCTGCA AACGA-3′; hbFGF, 5′-AAGCGGCTCTACTGCAAAA and the open wound area was expressed as a percentage of the wounded area at each time point divided by the A-3′ and 5′-CTTTCTGCCCAGGTCCTGTT-3′; hKGF, 5′-TTCACATTATCTGTCTAGTGGGT-3′ and 5′-TG area of its original wound at day 0.
To measure the granulation tissue area, wound tissues GGTCCCTTTTACTTTGCC-3′; hGAPDH, 5′-GAAGG TGAAGGTCGGAGTC-3′ and 5′-GAAGATGGTGAT were harvested at days 15 and 20, fixed in 4% paraformaldehyde (Sigma), and embedded in paraffin. Wound GGGATTTC-3′; mGAPDH, 5′-ATGACTCCACTCAC GGCAAA-3′ and 5′-ATGATGACCCTTTTGGCTCC-3′. sections from the least healed central region (maximal distance between the epithelial edges; considered to be Real-time PCR was performed with a SYBR-Green PCR master mix (Qiagen, Valencia, CA, USA) using Bioneer a central region of the wounds) were stained with hematoxylin and eosin (H&E). Then, the granulation tissue Exicycler TM 96 (Bioneer Corporation, Daejeon, Korea). Data analysis was based on the ∆∆Ct method with nor-area was analyzed with Image-Pro Plus by tracing the wound boundary that was considered as the presence of malization of the raw data to housekeeping gene, GAPDH, included in the experiment. All reactions were intact hair follicles and the transition from normal to hypertrophic epidermis, and calculating the pixel area performed in triplicate. (20) . Ten to 12 sections were examined for each wound.
Cell Proliferation and Migration Assay Immunohistochemistry
For the cell proliferation analysis, Pam212 and Hek001 cells were incubated in EPC-CM, in M199 basal Wound sections were treated with 0.3% hydrogen medium with or without human keratinocyte growth facperoxide to quench the endogenous peroxidase and then tor (KGF; 50 ng/ml, ProSpec-Tany Technogene, Rohoantigen epitopes were retrieved by heating in Target Revot, Israel) or human platelet-derived growth factor trieval Solution (DakoCytomation, Carpinteria, CA, (PDGF-BB; 10 ng/ml, ProSpec-Tany Technogene) at USA). After sections were blocked in 10% normal goat 37°C for 48 h. The cell number was then estimated by serum, they were treated with anti-von Willebrand factor measuring the absorbance at 540 nm after using a meth-(vWF; DakoCytomation), anti-cytokeratin14 (CK14; ylthiazolyldiphenyl-tetrazolium bromide (MTT, Sigma) Abcam, Cambridge, MA, USA), anti-vimentin (Dakoassay according to the manufacturer's instructions. Cytomation), anti-Ki67 (BD Bioscienece, San Jose, CA, A migration assay was performed using a modified USA), anti-human CD31 (Abcam), anti-mouse CD31
Boyden chamber (Costar, Cambridge, MA, USA), where (BD Bioscience), or irrelevant nonspecific IgG. Sections cells (Pam212, Hek001, NIH3T3, HDF) were placed in were then incubated with biotinylated or fluorescencethe upper chamber and the lower chamber was filled conjugated secondary IgGs (Jackson ImmunoResearch with EPC-CM, M199 basal medium, or M199 supple-Laboratories Inc., West Grove, PA, USA) and were vismented with KGF (50 ng/ml) or PDGF-BB (10 ng/ml). ualized using an ABC kit (Elite kit, Vector Laboratories, After incubation for 24 h, migrated cells that attached to Burlingame, CA, USA) and Vector Blue (Vector Labothe lower side of the filter were stained with Giemsa ratories). For multicolor immunofluorescence analysis, solution and counted. sections were further stained with 4,6-diamidino-2-phenylindole (DAPI) and imaged with a fluorescence mi-Statistical Analysis croscope (Carl Zeiss, Oberkochen, Germany).
All data are presented as mean ± SEM. Statistical sig-Reverse Transcriptase Polymerase Chain Reaction nificance was evaluated using paired t-test or one-way (RT-PCR) Analysis analysis of variance followed by Bonferroni's post hoc multiple comparison test. A value of p < 0.05 was con-Total RNA (1 µg) was extracted from EPCs or sidered statistically significant and the number of samwound tissues harvested at days 3 and 7 after surgery ples examined is indicated by n. and was processed for cDNA synthesis using the Superscript first-strand synthesis system (Invitrogen). The RESULTS cDNA was amplified with 30 to 35 cycles of PCR using EPC Transplantation Accelerates Wound Closure gene-specific primers as follows: hVEGF, 5′-CAAGGC in STZ-Induced Diabetic Mice CAGCACATAGGAGA-3′ and 5′-AGGGAACGCTC CAGGACTTA-3′; hPDGF-α, 5′-CCATTCGGAGGAA To evaluate the therapeutic effect of xenotransplantation of human cord blood-derived EPCs to heal STZ-GAGAAGC-3′ and 5′-GTATTCCACCTTGGCCACCT-3′; hPDGF-β, 5′-TCGAGATTGTGCGGAAGAAG-3′ induced diabetic wounds in athymic nude mice, diabetes was induced in athymic nude mice by injecting STZ. As and 5′-GTGTGCTTGAATTTCCGGTG-3′; hTGF-β1, expected from previous studies, the STZ-induced dia-process, wound sections retrieved at days 3 and 7 after injury were immunohistologically analyzed, as shown in betic mice displayed the markedly delayed wound healing (13). These mice achieved the 50% wound closure Figure 2 . From the earliest time points studied (day 3), a number of proliferating keratinocytes (positive for both by day 12, whereas normal athymic nude mice exhibited 50% closure by day 7 after wounding (data not shown).
CK14 and the proliferation marker, Ki67) were found in EPCs-treated wounds, especially in the basal layer adja-When EPCs were injected around full-thickness dermal wounds created on the diabetic nude mice, wound clo-cent to the thickened wound edge and in the distal epidermis, in contrast with a few proliferating keratinocytes sure was significantly accelerated as early as day 3 after injury compared to PBS (vehicle control)-treated wounds in PBS-treated controls ( Fig. 2A) . Notably, CK14-positive proliferating cells were also found at the outer root ( Fig. 1A, B ). This significant reduction in the open wound area was consistently observed until day 12 sheath of hair follicles in the neighboring intact skin, area known as keratinocyte reservoirs. Because follicu-(EPC, 10.6 ± 5.3%; PBS, 45.7 ± 9.2% on day 12, p < 0.05). In addition, the EPCs-treated wounds had a sub-lar keratinocytes, whose growth is arrested in normal skin, undergo mitosis and provide progeny to the epider-stantially reduced cross-sectional area of granulation tissues at day 20 compared with PBS-treated controls mis after wounding, they have been thought to play a crucial role in initiating rapid reepithelialization (10). (Fig. 1C) .
CK14/Ki67-positive cells within hair follicles were EPC Transplantation Promotes the Proliferation more frequently observed in EPCs-treated wounds than of Keratinocytes and Fibroblasts in the Early in PBS-treated controls. In addition, the immunohisto-Wound Healing Process chemical analysis of granulation tissue at day 7 after injury revealed that EPC transplantation promoted fibro-To carefully examine the cellular changes that occur with EPC transplantation during the early wound healing blast proliferation in the granulation tissue, in that EPCs- treated wounds exhibited more proliferating fibroblasts vealed that the intradermal application of EPC-CM accelerated the wound closure rate to the same extent as (positive for both vimentin and Ki67) than PBS-treated controls (Fig. 2B) .
EPC injection for the entire duration of study (Fig. 4B) . The EPC-CM-treated wounds had significantly smaller The Conditioned Medium From EPCs Exerts granulation tissue areas than those in the M199 controls Mitogenic and Chemotactic Effects on Keratinocytes (Fig. 4C) . Furthermore, the extent of this reduction in and Fibroblasts granulation tissue area was similar to that seen in EPCstransplanted wounds. These data indicate that EPC-CM To examine whether secreted factors from injected EPCs might directly stimulate keratinocyte and fibro-was therapeutically equivalent to EPCs in accelerating wound closure and reducing the granulation tissue area blast proliferation, growth factors and cytokines that are potentially relevant in dermal wound healing were ana-in STZ-induced diabetic mice.
To investigate whether the injection of EPC-CM lyzed using real-time PCR. The EPCs expressed a wide array of growth factors and cytokines, of which PDGF-might increase the neovascularization of wounded tissue as observed in EPCs-injected tissues, the capillary den-α, PDGF-β, and KGF were the most strongly expressed (Fig. 3A) . Consistently, RT-PCR analysis with wound sity was estimated by counting the vWF-positive neovessels in the granulation tissues of wound sections har-tissues using human-specific primers revealed that abundant mRNAs of human PDGF-α, PDGF-β, and KGF vested at day 15. Representative images and quantitative analysis displayed in Figure 4D and E showed that the were detected only in EPCs-treated wound tissues harvested at day 3 after injury (Fig. 3B ). Furthermore, these capillary density in EPC-CM-treated wounds was substantially greater than that in M199-treated controls. Al-paracrine factors released from human EPCs exhibited mitogenic and chemoattractant properties on keratino-though slightly less in magnitude, this enhancement was not significantly different from that observed in EPCs-cytes and fibroblasts. As shown in Figure 3C and D, EPC-CM significantly enhanced the proliferation of treated wounds. Immunohistological analysis with species-specific CD31 antibodies revealed that a few neo-both murine keratinocytes (Pam212) and fibroblasts (NIH3T3) to a comparable extent as their growth with vessels in the EPCs-treated wounds were lined with both mouse and human CD31-positive cells (Fig. 4F ). This human recombinant PDGF-BB, KGF, or bFGF proteins. Similar mitogenic activity of EPC-CM was observed in result indicates that injected human EPCs contributed to the neovascularization of wounded tissues, in part the same experiment with human keratinocytes (Hek001) and fibroblasts (HDF) (Fig. 3C, D) . In addition, the ef-through physically incorporating into the newly formed murine vasculature (vasculogenesis). However, EPC-fect of EPC-CM on the chemotactic migration of fibroblasts and keratinocytes was examined using transwell mediated postnatal vasculogenesis might not be a supportive mechanism to enhance neovascularization after migration assay. EPC-CM induced significant seven and twofold increases in the migration of murine and human EPC transplantation into diabetic wounds. fibroblasts respectively (Fig. 3E ), although it had no sig-DISCUSSION nificant effect on keratinocyte migration (data not shown).
The present study revealed that the transplantation of EPC-CM Is Therapeutically Equivalent to EPCs human cord blood-derived EPCs significantly accelerin its Ability to Enhance Wound Closure ated wound closure in diabetic mice from the earliest and Neovascularization in STZ-Induced Diabetic Mice time point studied, with enhanced keratinocyte/fibroblast proliferation and neovascularization. In particular, We next asked whether paracrine factors from injected EPCs made a contribution to accelerating the EPC transplantation appeared to stimulate the proliferation of CK14-positive keratinocytes in the basal layer of wound healing process in diabetic mice and evaluated the extent of their contribution to the enhanced skin re-the epidermis and the outer root sheath of hair follicles near the wound. This proliferation might have contrib-generation observed in EPCs-treated wounds. Concentrated EPC-CM (prepared from an overnight culture of uted to the rapid reepithelialization at early time point by supporting keratinocyte migration into the center of 1 × 10 6 EPCs) was intradermally injected into the same diabetic wound murine model and its effect on wound the wound bed where very few Ki67-positive proliferating cells were found. Because the activation of hair fol-healing was analyzed and compared with that of cell injection (1 × 10 6 EPCs). Macroscopic observation at in-licular keratinocytes is necessary to initiate rapid reepithelialization right after wounding, their progenies dicated time points in Figure 4 showed that wounds treated with EPC-CM had substantially smaller open constitute a significant portion of the new epidermis formed in wounded skin (10) . In this regard, the abun-wound area than M199 basal medium controls from the earliest time point studied. Notably, the paralleled com-dant proliferating follicular keratinocytes observed in the EPC-treated mice implied that the enhanced reepi-parison of EPC-CM-treated and EPC-injected groups re- 
thelialization made a great contribution in accelerating
Some studies have reported that >50% of the newly formed vasculature contains injected EPCs, whereas wound closure rate.
The finding that the EPC-treated wounds exhibited a other reports have shown only occasional EPC-incorporated capillaries, despite noting a substantial increase in number of Ki67-positive cells and rapid wound closure at very early wound healing process, suggested that the capillary density and improved tissue regeneration (23) . In this regard, our comparison of EPC-transplanted and EPCs might directly activate the proliferation of keratinocytes and fibroblasts. Indeed, the experiment with EPC-CM-injected wounds clearly addressed which mechanism was responsible for the observed EPC-medi-EPC-CM revealed that paracrine factors secreted from EPCs directly activated the proliferation of both keratin-ated wound healing effect. The present data suggest that paracrine factors released from EPCs are sufficient for ocytes and fibroblasts, and also promoted the chemotactic migration of fibroblasts. In the normal wound recov-efficient wound healing in diabetic mice and EPC-mediated vasculogenesis might not be responsible for the im-ery process, growth factors and cytokines are massively produced at the wounded skin sites and contribute to proved healing speed and enhanced neovascularization at wound sites that were observed in EPC transplanta-wound healing process, whereas their expressions in diabetic human and animal models are significantly re-tion. Although some of injected human EPCs were physically engrafted into the murine vasculature, the EPCs duced and delayed, thereby disrupting the normal healing process (2, 3, 24) . In particular, impaired wound appeared to increase wound revascularization mainly by stimulating angiogenesis rather than through postnatal healing in diabetes is associated with decreased expression levels of PDGF and KGF, indicating that certain vasculogenesis. The neovascularization effect of human EPCs in dia-expression levels are essential for normal wound repair (12, 22) . In this regard, PDGF and KGF released from betic mice was recently reported, wherein EPC transplantation ameliorated murine diabetic neuropathy by injected human EPCs might stimulate the keratinocytes and fibroblasts to proliferate and migrate. Or a well-enhancing vascularization around the peripheral nerves (8, 14) . However, these studies did not directly address orchestrated combination of many paracrine factors secreted from EPCs might more effectively accelerate the the effect of EPC transplantation on diabetic wound healing. The present study is the first to our knowledge wound healing process rather than one or two growth factors. Such a paracrine action of EPCs on keratino-to definitely characterize the therapeutic potential of human cord blood-derived EPCs in diabetic wound heal-cytes and fibroblasts has not yet been studied, although several previous studies have investigated the paracrine ing. Importantly, the present data demonstrate that EPC-CM is therapeutically equivalent to EPCs, at least in effect of EPCs on endothelial cells (7, 17) .
The aforementioned paracrine and vasculogenic ac-terms of wound closure rate, granulation tissue formation, and neovascularization. Although further study is tions of EPCs are well-characterized as mechanisms involved in EPC-mediated neovascularization process. required to define its composition, EPC-CM could serve as a potential therapeutic alternative without adverse im-However, it remains unclear which mechanism plays the dominant role in EPC-mediated tissue regeneration. Al-munological reaction to allografts that should be carefully considered when injecting any nonautologous cells. though numerous studies have documented the presence of injected EPCs at newly formed capillaries in injured 
